SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001628280-20-003880
Filing Date
2020-03-20
Accepted
2020-03-20 17:12:17
Documents
110
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 10-K cpix-20191231.htm   iXBRL 10-K 3116581
2 EX-10.11 a2019-10kxexhibit1011a.htm EX-10.11 49234
3 EX-10.12 a2019-10kxexhibit1012m.htm EX-10.12 49541
4 EX-10.13 a2019-10kxexhibit1013l.htm EX-10.13 49574
5 EX-10.14 a2019-10kxexhibit1014m.htm EX-10.14 49653
6 EX-10.15 a2019-10kxexhibit1015j.htm EX-10.15 48593
7 EX-23.1 a2019-10kxexhibit231co.htm EX-23.1 2901
8 EX-31.1 a2019-10kxexhibit311.htm EX-31.1 21158
9 EX-31.2 a2019-10kxexhibit312.htm EX-31.2 21211
10 EX-32.1 a2019-10kxexhibit321.htm EX-32.1 9353
16 cpix-20191231_g1.jpg GRAPHIC 104089
  Complete submission text file 0001628280-20-003880.txt   12429786

Data Files

Seq Description Document Type Size
11 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cpix-20191231.xsd EX-101.SCH 78583
12 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cpix-20191231_cal.xml EX-101.CAL 127786
13 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cpix-20191231_def.xml EX-101.DEF 345927
14 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cpix-20191231_lab.xml EX-101.LAB 847298
15 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cpix-20191231_pre.xml EX-101.PRE 574309
39 EXTRACTED XBRL INSTANCE DOCUMENT cpix-20191231_htm.xml XML 2146202
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-33637 | Film No.: 20732823
SIC: 2834 Pharmaceutical Preparations